Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIOP) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Fortress Biotech (FBIOP) over the last 7 years, with Q3 2025 value amounting to 1.65%.

  • Fortress Biotech's Return on Invested Capital fell 94400.0% to 1.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.65%, marking a year-over-year decrease of 94400.0%. This contributed to the annual value of 4.89% for FY2024, which is 9500.0% down from last year.
  • As of Q3 2025, Fortress Biotech's Return on Invested Capital stood at 1.65%, which was down 94400.0% from 22.14% recorded in Q4 2024.
  • Fortress Biotech's Return on Invested Capital's 5-year high stood at 12.2% during Q3 2023, with a 5-year trough of 111.2% in Q2 2023.
  • Its 5-year average for Return on Invested Capital is 9.61%, with a median of 1.23% in 2022.
  • As far as peak fluctuations go, Fortress Biotech's Return on Invested Capital crashed by -1099700bps in 2023, and later skyrocketed by 1218000bps in 2024.
  • Quarter analysis of 5 years shows Fortress Biotech's Return on Invested Capital stood at 0.85% in 2021, then tumbled by -219bps to 2.7% in 2022, then tumbled by -1040bps to 30.72% in 2023, then increased by 28bps to 22.14% in 2024, then soared by 93bps to 1.65% in 2025.
  • Its Return on Invested Capital stands at 1.65% for Q3 2025, versus 22.14% for Q4 2024 and 7.79% for Q3 2024.